We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Agency Moves to Improve AERS as Drug Safety Concerns Grow
Agency Moves to Improve AERS as Drug Safety Concerns Grow
March 23, 2005
The FDA has been gathering information from industry on technology strategy and tools for a proposed upgrade of its Adverse Event Reporting System (AERS) in the wake of mounting concerns over drug safety.